Changlin Wang

890 total citations
49 papers, 668 citations indexed

About

Changlin Wang is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Changlin Wang has authored 49 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cellular and Molecular Neuroscience, 23 papers in Molecular Biology and 23 papers in Physiology. Recurrent topics in Changlin Wang's work include Neuropeptides and Animal Physiology (25 papers), Pain Mechanisms and Treatments (19 papers) and Receptor Mechanisms and Signaling (11 papers). Changlin Wang is often cited by papers focused on Neuropeptides and Animal Physiology (25 papers), Pain Mechanisms and Treatments (19 papers) and Receptor Mechanisms and Signaling (11 papers). Changlin Wang collaborates with scholars based in China, Japan and United States. Changlin Wang's co-authors include Rui Wang, Ye Yu, Ning Gu, Hongmei Liu, Yun Cui, Yuri Oh, Qian Guo, Qiong Wu, Hailong Hu and Yujie Feng and has published in prestigious journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Changlin Wang

48 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changlin Wang China 16 264 257 160 124 39 49 668
Qingqing Shi China 18 314 1.2× 38 0.1× 100 0.6× 64 0.5× 14 0.4× 78 951
Ankang Hu China 19 355 1.3× 31 0.1× 41 0.3× 114 0.9× 14 0.4× 70 898
Bram van der Gaag Netherlands 12 154 0.6× 45 0.2× 30 0.2× 34 0.3× 58 1.5× 21 722
Mengxue Liu China 18 213 0.8× 81 0.3× 32 0.2× 99 0.8× 20 0.5× 83 971
Maohua Wang China 16 220 0.8× 18 0.1× 101 0.6× 68 0.5× 13 0.3× 58 1.0k
Sung‐Jin Yoon South Korea 17 406 1.5× 128 0.5× 95 0.6× 49 0.4× 2 0.1× 63 955
Dongwoo Kim South Korea 19 135 0.5× 77 0.3× 45 0.3× 175 1.4× 7 0.2× 76 915
Ziren Wang China 12 158 0.6× 33 0.1× 30 0.2× 69 0.6× 22 0.6× 72 648
Tingting Chen China 19 456 1.7× 19 0.1× 58 0.4× 94 0.8× 27 0.7× 62 1.1k

Countries citing papers authored by Changlin Wang

Since Specialization
Citations

This map shows the geographic impact of Changlin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Wang more than expected).

Fields of papers citing papers by Changlin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changlin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Wang. The network helps show where Changlin Wang may publish in the future.

Co-authorship network of co-authors of Changlin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Changlin Wang. A scholar is included among the top collaborators of Changlin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changlin Wang. Changlin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qing, Haichao Zhao, Changlin Wang, et al.. (2024). Durable hybrid metamaterial with hierarchically porous structure for efficient passive daytime radiative cooling. Chemical Engineering Journal. 498. 155516–155516. 19 indexed citations
2.
Mou, Xiangyu, et al.. (2024). Rehmannia glutinosa DC.-Lilium lancifolium Thunb. in the treatment of depression: a comprehensive review and perspectives. Frontiers in Pharmacology. 15. 1471307–1471307. 1 indexed citations
3.
Yu, Wenyan, Changlin Wang, Yuzhen Zhao, et al.. (2024). In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery. Science Advances. 10(33). eado3919–eado3919. 7 indexed citations
4.
Wang, Siyu, Yuzhe Zhang, Xiaohan Liu, et al.. (2024). BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects. European Journal of Pharmacology. 978. 176775–176775. 1 indexed citations
5.
Wang, Changlin, Fei Chang, Ye Li, et al.. (2024). Characteristics of locus coeruleus functional connectivity network in patients with comorbid migraine and insomnia. The Journal of Headache and Pain. 25(1). 159–159. 3 indexed citations
6.
7.
Wang, Changlin, et al.. (2022). Top 100 Cited Papers on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: A Bibliometric Study. Frontiers in Psychiatry. 13. 936009–936009. 3 indexed citations
8.
Han, Fang, Shuai Qu, Yuanfei Yao, et al.. (2018). MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development. Cell Death and Disease. 9(10). 999–999. 12 indexed citations
9.
Wang, Changlin, et al.. (2017). C-terminal hydrazide modification changes the spinal antinociceptive profiles of endomorphins in mice. Peptides. 99. 128–133. 11 indexed citations
11.
Gu, Ning, Hailong Hu, Qian Guo, et al.. (2015). Effects of oral administration of titanium dioxide fine-sized particles on plasma glucose in mice. Food and Chemical Toxicology. 86. 124–131. 21 indexed citations
13.
Wang, Changlin, Yukun Ren, Qiong Xiang, et al.. (2013). Characterization of opioid activities of endomorphin analogs with C-terminal amide to hydrazide conversion. Neuropeptides. 47(5). 297–304. 11 indexed citations
14.
Wang, Changlin, Chao Guo, Yiqing Wang, et al.. (2010). Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine. Peptides. 32(2). 293–299. 12 indexed citations
15.
Yu, Ye, Yun Cui, Xiang Wang, et al.. (2007). In vitro characterization of the effects of endomorphin 1 and 2, endogenous ligands for μ-opioid receptors, on mouse colonic motility. Biochemical Pharmacology. 73(9). 1384–1393. 30 indexed citations
16.
Wang, Changlin, Xiang Wang, Ye Yu, et al.. (2007). Type 1 Diabetes attenuates the modulatory effects of endomorphins on mouse colonic motility. Neuropeptides. 42(1). 69–77. 17 indexed citations
17.
Liu, Hongmei, et al.. (2006). Utilization of Combined Chemical Modifications to Enhance the Blood-Brain Barrier Permeability and Pharmacological Activity of Endomorphin-1. Journal of Pharmacology and Experimental Therapeutics. 319(1). 308–316. 61 indexed citations
18.
Liu, Hongmei, et al.. (2006). Endomorphin-1 analogs with enhanced metabolic stability and systemic analgesic activity: Design, synthesis, and pharmacological characterization. Bioorganic & Medicinal Chemistry. 15(4). 1694–1702. 18 indexed citations
19.
Yu, Ye, Changlin Wang, Yun Cui, et al.. (2005). C-terminal amide to alcohol conversion changes the cardiovascular effects of endomorphins in anesthetized rats. Peptides. 27(1). 136–143. 16 indexed citations
20.
Schut, Herman A.J., et al.. (1997). Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice fed a high ω-3 fatty acid diet. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 378(1-2). 23–30. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026